157 related articles for article (PubMed ID: 23234313)
1. Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.
McCarthy JM; Rasines Moreno B; Filippini D; Komber H; Maly M; Cernescu M; Brutschy B; Appelhans D; Rogers MS
Biomacromolecules; 2013 Jan; 14(1):27-37. PubMed ID: 23234313
[TBL] [Abstract][Full Text] [Related]
2. Influence of surface functionality of poly(propylene imine) dendrimers on protease resistance and propagation of the scrapie prion protein.
Fischer M; Appelhans D; Schwarz S; Klajnert B; Bryszewska M; Voit B; Rogers M
Biomacromolecules; 2010 May; 11(5):1314-25. PubMed ID: 20405854
[TBL] [Abstract][Full Text] [Related]
3. Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).
McCarthy JM; Franke M; Resenberger UK; Waldron S; Simpson JC; Tatzelt J; Appelhans D; Rogers MS
PLoS One; 2013; 8(1):e55282. PubMed ID: 23383136
[TBL] [Abstract][Full Text] [Related]
4. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
[TBL] [Abstract][Full Text] [Related]
5. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for prion disease treatment: new insights into the role of dendrimers.
McCarthy JM; Appelhans D; Tatzelt J; Rogers MS
Prion; 2013; 7(3):198-202. PubMed ID: 23764833
[TBL] [Abstract][Full Text] [Related]
7. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
8. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
9. Dendrimers destabilize proteins in a generation-dependent manner involving electrostatic interactions.
Giehm L; Christensen C; Boas U; Heegaard PM; Otzen DE
Biopolymers; 2008 Jun; 89(6):522-9. PubMed ID: 18203113
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
11. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
12. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
13. Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.
Schmitz M; Candelise N; Kanata E; Llorens F; Thüne K; Villar-Piqué A; da Silva Correia SM; Dafou D; Sklaviadis T; Appelhans D; Zerr I
Mol Neurobiol; 2020 Apr; 57(4):1863-1874. PubMed ID: 31848935
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
15. Guanidino- and urea-modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non-cytotoxic conditions. dependence on dendrimer generation and surface charge.
Cordes H; Boas U; Olsen P; Heegaard PM
Biomacromolecules; 2007 Nov; 8(11):3578-83. PubMed ID: 17918894
[TBL] [Abstract][Full Text] [Related]
16. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
17. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
18. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
19. Chemical induction of misfolded prion protein conformers in cell culture.
Ghaemmaghami S; Ullman J; Ahn M; St Martin S; Prusiner SB
J Biol Chem; 2010 Apr; 285(14):10415-23. PubMed ID: 19955177
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
